Recent news articles in the Washington Post and Bloomberg.com highlight China's efforts to move away from requiring animal testing of cosmetics, and the role of IIVS plays in providing much-needed training in alternative methods.
Read more about our
Currently China is striving to adopt and implement non-animal, including in vitro, testing approaches for the safety assessment of cosmetics and ingredients. Collaborative efforts between industry and the Institute for In Vitro Sciences (IIVS, Gaithersburg, USA) have focused on the transfer of several OECD Test Guideline methods to government laboratories in China and have supported the creation of an in vitro toxicology testing laboratory within the
GAITHERSBURG, Md.- In an effort to reduce the number of animals used in the registration and testing of cosmetics in China, US non-profit laboratory, the Institute for In Vitro Sciences (IIVS), provided in-depth training for two scientists from the Zhejiang Food and Drug Administration’s Institute for Food and Drug Control (ZJFDA IFDC). The course focused on laboratory techniques using more predictive and human relevant test methods such as reconstructed human skin and eye models. The training was designed to assist the agency in adopting non-animal methods as a means to evaluate and monitor...How the Good In Vitro Method Practices Guidance Document Can Help Implement New Toxicological Approaches: A Case Study in China
October 17, 2018US Institute Trains Chinese Scientists from Zhejiang FDA in Non-Animal Test Methods
August 31, 2015
IIVS President, Erin Hill, talked to Allure magazine about efforts to phase out animal testing of cosmetics in China and replace the practice with non-animal methods. The article, which appears in the November issue, examines that while animal testing is nearly non-existent in the U.S. and officially banned in the E.U., China’s regulatory agencies require animal testing of imported cosmetics and domestically manufactured ones, with some exceptions. Hill goes on to talk about the collaboration between IIVS and the Chinese government, citing the recently signed memorandum of understanding with...
We are pleased to share that today China’s National Medical Products Association (NMPA) has approved new methods for the regulations of cosmetics. Among these are two in vitro methods: DPRA for skin sensitization and the Short Time Exposure (STE) assay for eye irritation. IIVS’ International Outreach Program introduced these methods during its training ...
IIVS has worked collaboratively with international governments to help them implement non-animal test methods for the regulation of products and ingredients. Since 2010 a major area of focus has been working with the Chinese government to replace animal testing for the registration of cosmetics. This work is done under a Memorandum of Understanding with China’s Institute for Food and Drug Control (NIFDC). Together the NIFDC and IIVS train regulatory scientists in the execution of non-animal test methods, interpretation of resulting data, and incorporation of new methodologies into Technical ...
IIVS President, Erin Hill, and scientist, Quanshun Zhang attended the Congress on Alternative Methods in Guangzhou China. Dr. Zhang presented on the newly adopted 3T3 Phototoxicity Assay...
IIVS is pleased to see China providing a pathway for the importation of certain cosmetics without #animaltesting. The pathway does contain certain requirements that the international community must strive to meet - but it is certainly a major step forward. IIVS will continue its outreach with China's National Institute for Food and Drug Control (NIFDC), as well as with provincial FDA's, to continue to implement
IIVS and stakeholders around the world welcomed the announcement last month by the CFDA that data from a non-animal test method can now be used to substantiate the safety of cosmetics made in China. The test, known as the In Vitro 3T3 NRU Phototoxicity Test (OECD Test Guideline 432), measures a chemical's potential to cause harm after exposure to light.
The announcement came shortly after...First Non-Animal Test Method Accepted by China FDA
December 1, 2016